Skip to main content
NCBI home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1992;19(3):168–177.

Anticoagulation and Thrombolysis in Children

Maureen Andrew 1
PMCID: PMC326178  PMID: 15227435

Full text

PDF
168

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alpan G., Eyal F., Springer C., Glick B., Goder K., Armon J. Heparinization of alimentation solutions administered through peripheral veins in premature infants: a controlled study. Pediatrics. 1984 Sep;74(3):375–378. [PubMed] [Google Scholar]
  2. Andrew M., Paes B., Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol. 1990 Spring;12(1):95–104. doi: 10.1097/00043426-199021000-00019. [DOI] [PubMed] [Google Scholar]
  3. Andrew M., Paes B., Milner R., Johnston M., Mitchell L., Tollefsen D. M., Powers P. Development of the human coagulation system in the full-term infant. Blood. 1987 Jul;70(1):165–172. [PubMed] [Google Scholar]
  4. Bosque E., Weaver L. Continuous versus intermittent heparin infusion of umbilical artery catheters in the newborn infant. J Pediatr. 1986 Jan;108(1):141–143. doi: 10.1016/s0022-3476(86)80791-0. [DOI] [PubMed] [Google Scholar]
  5. Carpentieri U., Nghiem Q. X., Harris L. C. Clinical experience with an oral anticoagulant in children. Arch Dis Child. 1976 Jun;51(6):445–448. doi: 10.1136/adc.51.6.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chiu H. M., Hirsh J., Yung W. L., Regoeczi E., Gent M. Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis. Blood. 1977 Feb;49(2):171–184. [PubMed] [Google Scholar]
  7. Collen D., Lijnen H. R. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 1991 Dec 15;78(12):3114–3124. [PubMed] [Google Scholar]
  8. Corrigan J. J., Jr, Sleeth J. J., Jeter M., Lox C. D. Newborn's fibrinolytic mechanism: components and plasmin generation. Am J Hematol. 1989 Dec;32(4):273–278. doi: 10.1002/ajh.2830320407. [DOI] [PubMed] [Google Scholar]
  9. David R. J., Merten D. F., Anderson J. C., Gross S. Prevention of umbilical artery catheter clots with heparinized infusates. Dev Pharmacol Ther. 1981;2(2):117–126. [PubMed] [Google Scholar]
  10. Doyle J. J., Koren G., Cheng M. Y., Blanchette V. S. Anticoagulation with sodium warfarin in children: effect of a loading regimen. J Pediatr. 1988 Dec;113(6):1095–1097. doi: 10.1016/s0022-3476(88)80589-4. [DOI] [PubMed] [Google Scholar]
  11. Freed M. D., Keane J. F., Rosenthal A. The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation. 1974 Sep;50(3):565–569. doi: 10.1161/01.cir.50.3.565. [DOI] [PubMed] [Google Scholar]
  12. Freed M. D., Rosenthal A., Fyler D. Attempts to reduce arterial thrombosis after cardiac catheterization in children: use of percutaneous technique and aspirin. Am Heart J. 1974 Mar;87(3):283–286. doi: 10.1016/0002-8703(74)90065-9. [DOI] [PubMed] [Google Scholar]
  13. Hattersley P. G. Activated coagulation time of whole blood. JAMA. 1966 May 2;196(5):436–440. [PubMed] [Google Scholar]
  14. Hirsh J. Oral anticoagulant drugs. N Engl J Med. 1991 Jun 27;324(26):1865–1875. doi: 10.1056/NEJM199106273242606. [DOI] [PubMed] [Google Scholar]
  15. Ino T., Benson L. N., Freedom R. M., Barker G. A., Aipursky A., Rowe R. D. Thrombolytic therapy for femoral artery thrombosis after pediatric cardiac catheterization. Am Heart J. 1988 Mar;115(3):633–639. doi: 10.1016/0002-8703(88)90815-0. [DOI] [PubMed] [Google Scholar]
  16. Kisker C. T. Detection of fibrin monomer. Comparison of the immune precipitate method with the serial-dilution protamine sulfate test and the ethanol gel test. Am J Clin Pathol. 1979 Sep;72(3):405–409. doi: 10.1093/ajcp/72.3.405. [DOI] [PubMed] [Google Scholar]
  17. Lesko S. M., Mitchell A. A., Epstein M. F., Louik C., Giacoia G. P., Shapiro S. Heparin use as a risk factor for intraventricular hemorrhage in low-birth-weight infants. N Engl J Med. 1986 May 1;314(18):1156–1160. doi: 10.1056/NEJM198605013141805. [DOI] [PubMed] [Google Scholar]
  18. Moore R. A., McNicholas K. W., Naidech H., Flicker S., Gallagher J. D. Clinically silent venous thrombosis following internal and external jugular central venous cannulation in pediatric cardiac patients. Anesthesiology. 1985 May;62(5):640–643. doi: 10.1097/00000542-198505000-00018. [DOI] [PubMed] [Google Scholar]
  19. Rajani K., Goetzman B. W., Wennberg R. P., Turner E., Abildgaard C. Effect of heparinization of fluids infused through an umbilical artery catheter on catheter patency and frequency of complications. Pediatrics. 1979 Apr;63(4):552–556. [PubMed] [Google Scholar]
  20. Rao P. S., Thapar M. K., Rogers J. H., Jr, Strong W. B., Lutcher C. L., Nesbit R. R., Jr, Wray C. H. Effect of intraarterial injection of heparin on the complications of percutaneous arterial catheterization in infants and children. Cathet Cardiovasc Diagn. 1981;7(3):235–246. doi: 10.1002/ccd.1810070303. [DOI] [PubMed] [Google Scholar]
  21. Schmidt B., Andrew M. Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis Diagnosis and Treatment of Neonatal Thrombosis. Thromb Haemost. 1992 Mar 2;67(3):381–382. [PubMed] [Google Scholar]
  22. Schmidt B., Buchanan M. R., Ofosu F., Brooker L., Hirsh J., Andrew M. Antithrombotic properties of heparin in a neonatal piglet model of thrombin-induced thrombosis. Thromb Haemost. 1988 Oct 31;60(2):289–292. [PubMed] [Google Scholar]
  23. Schmidt B., Mitchell L., Ofosu F., Andrew M. Standard assays underestimate the concentration of heparin in neonatal plasma. J Lab Clin Med. 1988 Nov;112(5):641–643. [PubMed] [Google Scholar]
  24. Schmidt B., Ofosu F. A., Mitchell L., Brooker L. A., Andrew M. Anticoagulant effects of heparin in neonatal plasma. Pediatr Res. 1989 Apr;25(4):405–408. doi: 10.1203/00006450-198904000-00020. [DOI] [PubMed] [Google Scholar]
  25. Smith S., Dawson S., Hennessey R., Andrew M. Maintenance of the patency of indwelling central venous catheters: is heparin necessary? Am J Pediatr Hematol Oncol. 1991 Summer;13(2):141–143. doi: 10.1097/00043426-199122000-00005. [DOI] [PubMed] [Google Scholar]
  26. Vieira A., Berry L., Ofosu F., Andrew M. Heparin sensitivity and resistance in the neonate: an explanation. Thromb Res. 1991 Jul 1;63(1):85–98. doi: 10.1016/0049-3848(91)90272-x. [DOI] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES